BS
BIO icon

Banco Santander’s Bio-Rad Laboratories Class A BIO Stock Holding History

Banco Santander’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-834
Closed -$316K – 427
2023
Q2 		$316K Hold
834
– – ﹤0.01% 379
2023
Q1 		$400K Sell
834
-999
-55% -$468K 0.01% 312
2022
Q4 		$771K Hold
1,833
– – 0.01% 263
2022
Q3 		$765K Buy
+1,833
New +$914K 0.01% 267
2022
Q2 		– Sell
-4,000
Closed -$2.25M – 375
2022
Q1 		$2.25M Buy
+4,000
New +$2.41M 0.02% 223

Other funds holding BIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
VAM
Veritas Asset Management London, United Kingdom $5.9B AUM 3.19% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return